精神分裂症由患者来源脑类器官中的细胞特异性神经病理和多神经发育机制所定义
研究利用患者来源诱导多能干细胞生成三维脑类器官,模拟精神分裂症关键发育期的神经病理。精神分裂症类器官出现脑室神经病理、祖细胞存活改变和神经发生中断,导致发育中皮质区神经元减少。单细胞测序显示祖细胞神经元编程因子耗竭、细胞谱系重塑和分化轨迹改变,BRN2(POU3F2)和PTN在祖细胞和神经元中耗竭,二者分别作为神经发生和细胞存活的机制底物。
要点
- 精神分裂症脑类器官显示脑室神经病理、祖细胞存活改变和神经发生中断,皮质区神经元减少。
- 单细胞测序揭示祖细胞神经元编程因子耗竭、细胞谱系重塑、分化轨迹改变和皮质细胞类型多样性扭曲。
- BRN2(POU3F2)和PTN在精神分裂症祖细胞和神经元中耗竭,分别作为神经发生和细胞存活的机制底物。
核心结论
- 精神分裂症在患者来源类器官中存在多种机制,这些不同机制汇聚于原始脑发育通路如神经元分化、存活和生长因子支持,可能共同提升精神分裂症的内在风险。
研究设计与样本
- 利用患者来源诱导多能干细胞(iPSCs)生成三维脑类器官,以模拟精神分裂症关键期的神经病理,并与健康对照(Ctrls)来源类器官进行比较。
主要发现
- 精神分裂症类器官 exhibited 脑室神经病理,导致祖细胞存活改变和神经发生中断,最终在发育中的皮质区产生较少的神经元。
- 单细胞测序显示精神分裂症祖细胞特异性耗竭神经元编程因子,导致细胞谱系重塑、分化轨迹改变和皮质细胞类型多样性扭曲。
- 精神分裂症类器官与健康对照类器官在大分子多样性上相似,但四种GWAS因子(PTN、COMT、PLCL1和PODXL)以及属于POU域转录因子家族的肽段(如POU3F2/BRN2)发生改变。
- 单细胞测序识别出神经元编程因子的细胞类型特异性改变以及神经营养生长因子表达的发育转换,表明精神分裂症神经病理可按细胞类型逐一编码。
- 单细胞测序在精神分裂症祖细胞和神经元中均特异性地重现了BRN2(POU3F2)和PTN的耗竭。
关键数值与推荐
- 精神分裂症类器官与健康对照类器官在大分子多样性上相似,但四种GWAS因子(PTN、COMT、PLCL1和PODXL)以及POU域转录因子家族肽段(如POU3F2/BRN2)存在改变。
- 单细胞测序在精神分裂症祖细胞和神经元中均特异性地重现了BRN2(POU3F2)和PTN的耗竭。
- 两项机制性挽救实验 identify BRN2和PTN分别作为精神分裂症类器官中神经发生和细胞存活的机制底物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Due to an inability to ethically access developing human brain tissue as well as identify prospective cases, early-arising neurodevelopmental and cell-specific signatures of Schizophrenia (Scz) have remained unknown and thus undefined. To overcome these challenges, we utilized patient-derived induced pluripotent stem cells (iPSCs) to generate 3D cerebral organoids to model neuropathology of Scz during this critical period. We discovered that Scz organoids exhibited ventricular neuropathology resulting in altered progenitor survival and disrupted neurogenesis. This ultimately yielded fewer neurons within developing cortical fields of Scz organoids. Single-cell sequencing revealed that Scz progenitors were specifically depleted of neuronal programming factors leading to a remodeling of cell-lineages, altered differentiation trajectories, and distorted cortical cell-type diversity. While Scz organoids were similar in their macromolecular diversity to organoids generated from healthy controls (Ctrls), four GWAS factors (PTN, COMT, PLCL1, and PODXL) and peptide fragments belonging to the POU-domain transcription factor family (e.g., POU3F2/BRN2) were altered. This revealed that Scz organoids principally differed not in their proteomic diversity, but specifically in their total quantity of disease and neurodevelopmental factors at the molecular level. Single-cell sequencing subsequently identified cell-type specific alterations in neuronal programming factors as well as a developmental switch in neurotrophic growth factor expression, indicating that Scz neuropathology can be encoded on a cell-type-by-cell-type basis. Furthermore, single-cell sequencing also specifically replicated the depletion of BRN2 (POU3F2) and PTN in both Scz progenitors and neurons. Subsequently, in two mechanistic rescue experiments we identified that the transcription factor BRN2 and growth factor PTN operate as mechanistic substrates of neurogenesis and cellular survival, respectively, in Scz organoids. Collectively, our work suggests that multiple mechanisms of Scz exist in patient-derived organoids, and that these disparate mechanisms converge upon primordial brain developmental pathways such as neuronal differentiation, survival, and growth factor support, which may amalgamate to elevate intrinsic risk of Scz.
引用
- Notaras M, Lodhi A, Dündar F, et al. Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. Mol Psychiatry. 2021. PMID: 34789849. doi:10.1038/s41380-021-01316-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。